Interval-training and Appetite Regulation in Patients With Type 2 Diabetes
试验速览
- 阶段
- 不适用
- 入组人数
- 14
- 试验地点
- 2
- 主要终点
- Ad-libitum meal energy intake
研究概览
简要总结
Four months of interval walking (IW) training results in substantial weight loss in opposition to energy-expenditure matched continuous walking (CW) training. The reason for this is unclear.
This study will assess if IW leads to greater exercise-induced suppression of appetite and ad libitum food intake compared to CW and no exercise.
Subjects with type 2 diabetes will be included in a crossover, counter-balanced, controlled study, where each subject will undergo three trials. Trials will be identical except the following interventions:
- One hour of rest (CON)
- One hour of interval walking (repeated cycles of 3 min of fast and 3 min of slow walking; IW)
- One hour of continuous walking (CW) matched to IW with regards to energy-expenditure.
After the interventions subjects will undergo a liquid mixed meal tolerance test (450 kCal), with regular measurements of appetite-related hormones (insulin, ghrelin, Leptin, Cholecystokinin, PYY). Three hours into the mixed meal tolerance test, a standardised ad-libitum meal test will be served and intake will recorded. Free-living energy intake via food records will be assessed during the following 32 hours.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 Diabetes Mellitus
- •BMI > 25
排除标准
- •Pregnancy
- •Contraindication to increased levels of physical activity
- •Eating disorder
- •Insulin dependence
结局指标
主要结局
Ad-libitum meal energy intake
时间窗: Initiated 3 hours after the intervention
Subjects will receive a standardized ad-libitum meal and energy intake will be assessed
次要结局
- Satiety(Regular assessments for 36 hours following the intervention)
- Free-living energy intake(For 32 hours following the ad-libitum meal.)
- Appetite-related hormones(Regularly during the 3 hours following the intervention)
研究者
Anders Rasmussen Rinnov
MD, PhD
Rigshospitalet, Denmark
